




Instance: composition-en-d51291e7d675a24203f1a2e152221f98
InstanceOf: CompositionUvEpi
Title: "Composition for desloratadine Package Leaflet"
Description:  "Composition for desloratadine Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpd51291e7d675a24203f1a2e152221f98)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - desloratadine"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet:</p>
<ol>
<li>What Desloratadine Teva is and what it is used for </li>
<li>What you need to know before you take Desloratadine Teva </li>
<li>How to take Desloratadine Teva </li>
<li>Possible side effects </li>
<li>How to store Desloratadine Teva </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What desloratadine is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What desloratadine is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Desloratadine Teva is 
Desloratadine Teva contains desloratadine which is an antihistamine. </p>
<p>How Desloratadine Teva works 
Desloratadine Teva is an antiallergy medicine that does not make you drowsy. It helps control your allergic 
reaction and its symptoms. </p>
<p>When Desloratadine Teva should be used 
Desloratadine Teva relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages 
caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of 
age and older. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery 
eyes. </p>
<p>Desloratadine Teva is also used to relieve the symptoms associated with urticaria (a skin condition caused by 
an allergy). These symptoms include itching and hives. </p>
<p>Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take desloratadine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take desloratadine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Desloratadine Teva 
* if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or 
to loratadine. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Desloratadine Teva 
* if you have poor kidney function. 
* if you have medical or familial history of seizures. </p>
<p>Use in children and adolescents 
 Do not give this medicine to children less than 12 years of age. </p>
<p>Other medicines and Desloratadine Teva 
There are no known interactions of Desloratadine Teva with other medicines. 
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. </p>
<p>Desloratadine Teva with food, drink and alcohol 
Desloratadine Teva may be taken with or without a meal.<br />
Use caution when taking Desloratadine Teva with alcohol. </p>
<p>Pregnancy, breast-feeding and fertility 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your 
doctor or pharmacist for advice before taking this medicine.<br />
Taking Desloratadine Teva is not recommended if you are pregnant or nursing a baby. 
Fertility 
There is no data available on male/female fertility. </p>
<p>Driving and using machines 
At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. 
Although most people do not experience drowsiness, it is recommended not to engage in activities requiring 
mental alertness, such as driving a car or operating machinery until you have established your own response 
to the medicinal product. </p>
<p>Desloratadine Teva contains lactose 
Desloratadine Teva contains lactose. If you have been told by your doctor that you have an intolerance to 
some sugars, contact your doctor before taking this medicine. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take desloratadine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take desloratadine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or 
pharmacist if you are not sure. </p>
<p>Adults and adolescents 12 years of age and over<br />
The recommended dose is one tablet once a day with water, with or without food. </p>
<p>This medicine is for oral use. 
Swallow the tablet whole. </p>
<p>Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you are suffering 
from and will determine for how long you should take Desloratadine Teva. 
If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 
4 weeks), your doctor will recommend you a treatment schedule that will depend on the evaluation of the 
history of your disease. 
If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 
4 weeks), your doctor may recommend you a longer term treatment. </p>
<p>For urticaria, the duration of treatment may be variable from patient to patient and therefore you should 
follow the instructions of your doctor. </p>
<p>If you take more Desloratadine Teva than you should 
Take Desloratadine Teva only as it is prescribed for you. No serious problems are expected with accidental 
overdose. However, if you take more Desloratadine Teva than you were told to, tell your doctor, pharmacist 
or nurse immediately. </p>
<p>If you forget to take Desloratadine Teva 
If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing 
schedule. Do not take a double dose to make up for a forgotten dose. </p>
<p>If you stop taking Desloratadine Teva 
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>During the marketing of Desloratadine Teva, cases of severe allergic reactions (difficulty in breathing, 
wheezing, itching, hives and swelling) have been reported very rarely. If you notice any of these serious side 
effects, stop taking the medicine and seek urgent medical advice straight away. </p>
<p>In clinical studies in adults, side effects were about the same as with a dummy tablet. However, fatigue, dry 
mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the 
most commonly reported side effect. </p>
<p>In clinical studies with desloratadine, the following side effects were reported as: </p>
<p>Common: the following may affect up to 1 in 10 people 
  fatigue 
  dry mouth 
  headache </p>
<p>Adults 
During the marketing of Desloratadine Teva, the following side effects were reported as:  </p>
<p>Very rare: the following may affect up to 1 in 10,000 people 
  severe allergic reactions<br />
  rash  </p>
<p>pounding or irregular heartbeat 
  fast heartbeat </p>
<p>stomach ache </p>
<p>feeling sick (nausea) 
  vomiting  </p>
<p>upset stomach </p>
<p>diarrhoea 
  dizziness  </p>
<p>drowsiness<br />
  inability to sleep 
  muscle pain </p>
<p>hallucinations </p>
<p>seizures 
  restlessness with increased  </p>
<p>liver inflammation 
  abnormal liver function tests 
   body movement </p>
<p>Not known: frequency cannot be estimated from the available data 
  unusual weakness </p>
<p>yellowing of the skin and/or eyes 
  increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV 
lights of a solarium 
  changes in the way the heart beats 
  abnormal behaviour 
  aggression 
  weight increased 
  increased appetite 
  depressed mood 
  dry eyes </p>
<p>Children 
Not known: frequency cannot be estimated from the available data 
  slow heartbeat </p>
<p>change in the way the heart beats 
  abnormal behaviour </p>
<p>aggression </p>
<p>Reporting of side effects  </p>
<p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed 
in this leaflet.<br />
You can also report side effects directly via the national reporting system listed in Appendix V*. By 
reporting side effects you can help provide more information on the safety of this medicine.  </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store desloratadine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store desloratadine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blister after  EXP . The 
expiry date refers to the last day of that month. </p>
<p>This medicinal product does not require any special storage conditions. </p>
<p>Do not use this medicine if you notice any change in the appearance of the tablets. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw 
away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Desloratadine Teva contains<br />
- The active substance is 5 mg desloratadine. 
- The other ingredients are microcrystalline cellulose, pregelatinised maize starch, talc, silica colloidal 
anhydrous, lactose monohydrate, hypromellose, titanium dioxide (E171), macrogol 400, indigo 
carmine (E132). </p>
<p>What Desloratadine Teva looks like and contents of the pack 
Blue, round, biconvex film-coated tablet, plain on both sides. Desloratadine Teva 5 mg film-coated tablets 
are supplied in blister packs of 7, 10, 14, 20, 21, 28, 30, 40, 50, 60, 90, 100 and 105 film-coated tablets and 
in perforated blister packs of 50 x 1 film-coated tablet (unit dose). Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder and Manufacturer  </p>
<p>Marketing Authorisation Holder 
Teva B.V. 
Swensweg 5 
2031 GA Haarlem 
The Netherlands </p>
<p>Manufacturer 
TEVA Pharmaceutical Works Private Limited Company 
Pallagi  t 13, 
4042 Debrecen, 
Hungary </p>
<p>or </p>
<p>Pharmachemie B.V. 
Swensweg 5, 
2031 GA Haarlem, 
The Netherlands </p>
<p>or 
Merckle GmbH 
Ludwig-Merckle-Strasse 3 
D-89143 Blaubeuren 
Germany </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Teva Pharma Belgium N.V./S.A./AG 
T l/Tel: +32 38207Lietuva 
UAB Teva Baltics 
Tel: +370 52660  </p>
<p>Te : +359 24899Luxembourg/Luxemburg 
Teva Pharma Belgium N.V./S.A./AG 
Belgique/Belgien 
T l/Tel: +32 38207 esk  republika 
Teva Pharmaceuticals CR, s.r.o. 
Tel: +420 251007Magyarorsz g 
Teva Gy gyszergy r Zrt. 
Tel: +36 12886Danmark 
Teva Denmark A/S 
Tlf: +45 44985Malta 
Teva Pharmaceuticals Ireland 
L-Irlanda 
Tel: +44 2075407Deutschland 
TEVA GmbH 
Tel: +49 73140Nederland 
Teva Nederland B.V. 
Tel: +31 8000228Eesti </p>
<p>UAB Teva Baltics Eesti filiaal 
Tel: +372 6610Norge 
Teva Norway AS 
Tlf: +47 66775<br />
Specifar A.B.E.E. 
 : +30 2118805 sterreich 
ratiopharm Arzneimittel Vertriebs-GmbH 
Tel: +43 1970Espa a 
Teva Pharma, S.L.U. 
Tel: +34 913873Polska 
Teva Pharmaceuticals Polska Sp. z o.o. 
Tel: +48 223459France 
Teva Sant<br />
T l: +33 155917Portugal 
Teva Pharma - Produtos Farmac uticos, Lda. 
Tel: +351 214767Hrvatska 
Pliva Hrvatska d.o.o. 
Tel: + 385 13720Rom nia 
Teva Pharmaceuticals S.R.L. 
Tel: +40 212306Ireland 
Teva Pharmaceuticals Ireland 
Tel: +44 2075407Slovenija 
Pliva Ljubljana d.o.o. 
Tel: +386 15890 sland 
Alvogen ehf. 
S mi: +354 5222Slovensk  republika 
TEVA Pharmaceuticals Slovakia s.r.o. 
Tel: +421 257267Italia 
Teva Italia S.r.l. 
Tel: +39 028917Suomi/Finland 
SanoSwiss UAB 
Puh/Tel: +370 70001<br />
Specifar A.B.E.E. </p>
<p>: +30 2118805Sverige 
Teva Sweden AB 
Tel: +46 42121Latvija 
UAB Teva Baltics fili le Latvij <br />
Tel: +371 67323United Kingdom (Northern Ireland) 
Teva Pharmaceuticals Ireland 
Ireland 
Tel: +44 2075407This leaflet was last revised in  </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      



Instance: composition-da-d51291e7d675a24203f1a2e152221f98
InstanceOf: CompositionUvEpi
Title: "Composition for desloratadine Package Leaflet"
Description:  "Composition for desloratadine Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mpd51291e7d675a24203f1a2e152221f98)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - desloratadine"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #da
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Oversigt over indlægssedlen 
1. Virkning og anvendelse 
2. Det skal du vide, før du begynder at tage Desloratadine Teva 
3. Sådan skal du tage Desloratadine Teva 
4. Bivirkninger<br />
5. Opbevaring 
6. Pakningsstørrelser og yderligere oplysninger </p>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What desloratadine is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What desloratadine is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Hvad Desloratadine Teva er 
Desloratadine Teva indeholder desloratadin, som er et antihistamin. </p>
<p>Sådan virker Desloratadine Teva 
Desloratadine Teva er et lægemiddel mod allergi, som ikke gør dig døsig. Det hjælper med at regulere 
din allergiske reaktion og dens symptomer </p>
<p>Hvornår Desloratadin Teva skal bruges 
Desloratadine Teva lindrer symptomer forbundet med allergisk snue (inflammation af næsepassager 
forårsaget af allergi, for eksempel høfeber eller støvmideallergi). Symptomerne indbefatter nysen, 
løbende eller kløende næse, kløe i ganen og kløende, røde eller løbende øjne. </p>
<p>Desloratadine Teva anvendes også til at lindre symptomerne i forbindelse med nældefeber (en 
hudlidelse forårsaget af allergi) hos voksne og unge i alderen 12 år og derover. Symptomerne 
indbefatter kløe og kløende udslæt. </p>
<p>Lindring af disse symptomer varer en hel dag og hjælper dig med at genoptage dine normale daglige 
aktiviteter og søvn. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take desloratadine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take desloratadine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag ikke Desloratadine Teva </p>
<ul>
<li>hvis du er allergisk over for desloratadin eller et af de øvrige indholdsstoffer i Desloratadine 
Teva (angivet i afsnit 6) eller over for loratadin. </li>
</ul>
<p>Advarsler og forsigtighedsregler 
- hvis du har dårlig nyrefunktion.<br />
- hvis du tidligere har haft krampeanfald eller nogen i familien har haft det. </p>
<p>Børn og unge 
Giv ikke dette lægemiddel til børn under 12 år. </p>
<p>Brug af anden medicin sammen med Desloratadine Teva 
Der er ingen kendte interaktioner mellem Desloratadine Teva og andre lægemidler. 
Fortæl det altid til lægen eller apotekspersonalet, for nylig har taget anden medicin eller planlægger at 
tage anden medicin. </p>
<p>Brug af Desloratadine Teva sammen med mad, drikke og alkohol 
Desloratadine Teva kan tages med eller uden mad. 
Du skal udvise forsigtighed, hvis du tager Desloratadine Teva sammen med alkohol. </p>
<p>Graviditet, amning og frugtbarhed 
Hvis du er gravid eller ammer, har mistanke om, at du er gravid, eller planlægger at blive gravid, skal 
du spørge din læge eller apotekspersonalet til råds, før du tager dette lægemiddel. 
Det frarådes, at du tager Desloratadine Teva, hvis du er gravid, eller hvis du ammer dit spædbarn. </p>
<p>Frugtbarhed 
Der er ingen information tilgængelig om virkningen på frugtbarheden hos mænd og kvinder. </p>
<p>Trafik- og arbejdssikkerhed 
Ved den anbefalede dosis forventes dette lægemiddel ikke at påvirke evnen til at køre bil og betjene 
maskiner. Selvom de fleste mennesker ikke oplever døsighed, frarådes det at beskæftige sig med 
aktiviteter, der kræver mental årvågenhed, for eksempel køre bil og betjene maskiner, indtil din 
reaktion på dette lægemiddel er fastlagt. </p>
<p>Desloratadine Teva indeholder lactose 
Desloratadine Teva indeholder lactose. Kontakt lægen, før du tager denne medicin, hvis lægen har 
fortalt dig, at du ikke tåler visse sukkerarter. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take desloratadine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take desloratadine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Tag altid lægemidlet nøjagtigt efter lægens eller apotekspersonalets anvisning. Er du i tvivl, så spørg 
lægen eller apotekspersonalet. </p>
<p>Voksne og unge i alderen 12 år og derover<br />
Den anbefalede dosis er en tablet en gang dagligt sammen med vand, med eller uden mad. </p>
<p>Dette lægemiddel skal tages gennem munden. 
Tabletten skal sluges hel. </p>
<p>Med hensyn til varigheden af behandlingen, vil din læge bestemme hvilken type allergisk snue, du 
lider af, og vil fastsætte, hvor længe du skal tage Desloratadine Teva. 
Hvis din allergiske snue er forbigående (tilstedeværelse af symptomer i mindre end 4 dage per uge 
eller i mindre end 4 uger), vil din læge anbefale dig en behandlingsplan, som vil afhænge af 
vurderingen af din sygdomshistorie. 
Hvis din allergiske snue er vedvarende (tilstedeværelse af symptomer i 4 dage eller mere per uge og i 
mere end 4 uger), vil din læge måske anbefale dig en længerevarende behandling. </p>
<p>For nældefeber kan varigheden af behandling variere fra patient til patient, og du skal derfor følge din 
læges instruktioner. </p>
<p>Hvis du har taget for meget Desloratadine Teva-tabletter<br />
Tag udelukkende Desloratadine Teva således, som det er ordineret til dig. Ved fejlagtig overdosis 
forventes ingen alvorlige problemer. Men kontakt straks lægen, apotekspersonalet eller 
sygeplejersken, hvis du tager flere Desloratadine Teva, end du har fået besked på. </p>
<p>Hvis du har glemt at bruge Desloratadine Teva 
Hvis du glemmer at tage din medicin til tiden, så tag den snarest muligt og vend derefter tilbage til din 
sædvanlige medicineringsplan. Du må ikke tage en dobbeltdosis som erstatning for den glemte dosis. </p>
<p>Hvis du holder op med at tage Desloratadine Teva 
Spørg lægen eller apotekspersonalet, hvis der er noget, du er i tvivl om. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Dette lægemiddel kan som alle andre lægemidler give bivirkninger, men ikke alle får bivirkninger. </p>
<p>Under markedsføringen af Desloratadine Teva er der rapporteret meget sjældne tilfælde af alvorlige 
allergiske reaktioner (vejrtrækningsbesvær, hiven efter vejret, kløe, nældefeber og hævelse). Stop med 
at tage medicinen og søg straks akut lægehjælp, hvis du får nogle af disse alvorlige bivirkninger. </p>
<p>I kliniske studier med voksne var bivirkningerne nogenlunde de samme som ved en placebotablet. 
Træthed, mundtørhed og hovedpine blev imidlertid rapporteret hyppigere end ved en placebotablet. 
Hovedpine var den mest almindelige rapporterede bivirkning hos unge. </p>
<p>I kliniske studier med desloratadin er følgende bivirkninger blevet rapporteret: </p>
<p>Almindelig: følgende kan forekomme hos op til 1 ud af 10 personer 
● træthed 
● mundtørhed 
● hovedpine </p>
<p>Voksne 
Efter markedsføring af Desloratadine Teva er følgende bivirkninger blevet rapporteret: </p>
<p>Meget sjælden: følgende kan forekomme hos op til 1 ud af 10.000 personer 
● alvorlige allergiske reaktioner ● udslæt </p>
<p>●hjertebanken eller 
● hurtig hjerterytme (puls) </p>
<p>● mavesmerter </p>
<p>uregelmæssig hjerterytme 
● opkastning </p>
<p>● mavebesvær </p>
<p>● kvalme 
● svimmelhed </p>
<p>● døsighed  </p>
<p>● diarré 
● muskelsmerter  </p>
<p>● hallucinationer<br />
● søvnbesvær 
● rastløshed med øget  </p>
<p>● leverbetændelse<br />
● krampeanfald 
   kropsbevægelse  </p>
<p>● unormale prøver  </p>
<p>for leverfunktion </p>
<p>Ikke kendt: hyppigheden kan ikke vurderes ud fra tilgængelige data 
● usædvanlig mathedsfølelse 
● huden og/eller øjnene får en gullig farve 
● øget hudfølsomhed over for sollys, selv i overskyet vejr, og over for ultraviolet (UV) lys, f.eks. UV-
lys i et solarium 
● ændringer i måden hjertet slår 
● unormal adfærd 
● aggression 
● vægtforøgelse 
● øget appetit 
● nedtrykt sindstilstand 
● øjentørhed </p>
<p>Børn 
Ikke kendt: hyppigheden kan ikke vurderes ud fra tilgængelige data 
● langsomme hjerteslag<br />
● ændring i måden hjertet slår 
● unormal adfærd  </p>
<p>● aggression </p>
<p>Indberetning af bivirkninger 
Hvis du oplever bivirkninger, bør du tale med din læge eller apotekspersonalet. Dette gælder også 
mulige bivirkninger, som ikke er medtaget i denne indlægsseddel. Du eller dine pårørende kan også 
indberette bivirkninger direkte til Lægemiddelstyrelsen via det nationale rapporteringssystem anført i 
Appendiks V. Ved at indrapportere bivirkninger kan du hjælpe med at fremskaffe mere information 
om sikkerheden af dette lægemiddel. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store desloratadine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store desloratadine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Opbevar lægemidlet utilgængeligt for børn. </p>
<p>Tag ikke lægemidlet efter den udløbsdato, der står på æsken og blisteren efter "EXP". Udløbsdatoen er 
den sidste dag i den nævnte måned. </p>
<p>Denne medicin kræver ikke særlige opbevaringsforhold. </p>
<p>Tag ikke lægemidler, hvis du bemærker ændringer i tabletternes udseende. </p>
<p>Spørg apotekspersonalet, hvordan du skal bortskaffe medicinrester. Af hensyn til miljøet må du ikke 
smide medicinrester i afløbet, toilettet eller skraldespanden. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Desloratadine Teva indeholder:</p>
<ul>
<li>Aktivt stof: 5 mg desloratadin </li>
<li>Øvrige indholdsstoffer: mikrokrystallinsk cellulose, prægelatineret majsstivelse, talcum, kolloid 
vandfri silica, lactosemonohydrat, hypromellose, titandioxid (E171), macrogol 400, indigotin 
(E132). </li>
</ul>
<p>Udseende og pakningsstørrelser 
Blå, runde, bikonvekse, filmovertrukne tabletter, uden print på begge sider. Desloratadin Teva 5 mg 
filmovertrukne tabletter er pakket i blisterpakninger med 7, 10, 14, 20, 21, 28, 30, 40, 50, 60, 90, og 105 filmovertrukne tabletter og i perforerede enkeltdosisblisterpakninger med 50 x 1 
filmovertrukket tablet (enkeltdosispakning). </p>
<p>Ikke alle pakningsstørrelser er nødvendigvis markedsført. </p>
<p>Indehaver af markedsføringstilladelsen og fremstiller </p>
<p>Indehaver af markedsføringstilladelsen 
Teva B.V. 
Swensweg 5 
2031 GA Haarlem 
Holland </p>
<p>Fremstiller 
TEVA Pharmaceutical Works Private Limited Company 
Pallagi út 4042 Debrecen 
Ungarn </p>
<p>eller </p>
<p>Pharmachemie B.V. 
Swensweg 5 
2031 GA Haarlem 
Holland </p>
<p>eller </p>
<p>Merckle GmbH 
Ludwig-Merckle-Strasse 3 
89143 Blaubeuren 
Tyskland </p>
<p>Hvis du ønsker yderligere oplysninger om dette lægemiddel, skal du henvende dig til den lokale 
repræsentant for indehaveren af markedsføringstilladelsen: </p>
<p>België/Belgique/Belgien 
Teva Pharma Belgium N.V./S.A./AG 
Tél/Tel: +32 38207 
Lietuva 
UAB Teva Baltics 
Tel: +370 52660 
България 
Тева Фарма ЕАД 
Teл: +359 24899 
Luxembourg/Luxemburg 
Teva Pharma Belgium N.V./S.A./AG 
Belgique/Belgien 
Tél/Tel: +32 38207 
Česká republika 
Teva Pharmaceuticals CR, s.r.o. 
Tel: +420 251007 
Magyarország 
Teva Gyógyszergyár Zrt. 
Tel: +36 12886 
Danmark 
Teva Denmark A/S 
Tlf: +45 44985 
Malta 
Teva Pharmaceuticals Ireland 
L-Irlanda 
Tel: +44 2075407 
Deutschland 
TEVA GmbH 
Tel: +49 73140 
Nederland 
Teva Nederland B.V. 
Tel: +31 8000228 
Eesti </p>
<p>UAB Teva Baltics Eesti filiaal 
Tel: +372 6610 
Norge 
Teva Norway AS 
Tlf: +47 66775 
Ελλάδα 
Specifar A.B.E.E. 
Τηλ: +30 2118805 
Österreich 
ratiopharm Arzneimittel Vertriebs-GmbH 
Tel: +43 1970 
España 
Teva Pharma, S.L.U. 
Tel: +34 913873 
Polska 
Teva Pharmaceuticals Polska Sp. z o.o. 
Tel: +48 223459 
France 
Teva Santé 
Tél: +33 155917 
Portugal 
Teva Pharma - Produtos Farmacêuticos, Lda. 
Tel: +351 214767 
Hrvatska 
Pliva Hrvatska d.o.o. 
Tel: + 385 13720 
România 
Teva Pharmaceuticals S.R.L. 
Tel: +40 212306 
Ireland 
Teva Pharmaceuticals Ireland 
Tel: +44 2075407 
Slovenija 
Pliva Ljubljana d.o.o. 
Tel: +386 15890 
Ísland 
Alvogen ehf. 
Sími: +354 5222 
Slovenská republika 
TEVA Pharmaceuticals Slovakia s.r.o. 
Tel: +421 257267 
Italia 
Teva Italia S.r.l. 
Tel: +39 028917 
Suomi/Finland 
SanoSwiss UAB 
Puh/Tel: +370 70001 
Κύπρος 
Specifar A.B.E.E. 
Ελλάδα 
Τηλ: +30 2118805 
Sverige 
Teva Sweden AB 
Tel: +46 42121 
Latvija 
UAB Teva Baltics filiāle Latvijā<br />
Tel: +371 67323 
United Kingdom (Northern Ireland) 
Teva Pharmaceuticals Ireland 
Ireland 
Tel: +44 2075407 </p>
<p>Denne indlægsseddel blev senest ændret  </p>
<p>Du kan finde yderligere oplysninger om dette lægemiddel på Det Europæiske Lægemiddelagenturs 
hjemmeside http://www.ema.europa.eu/ </p>
<p>BILAG IV </p>
<p>VIDENSKABELIGE KONKLUSIONER OG BEGRUNDELSER FOR ÆNDRING AF 
BETINGELSERNE 
FOR MARKEDSFØRINGSTILLADELSEN/-TILLADELSERNE </p>
<p>Videnskabelige konklusioner </p>
<p>Under hensyntagen til PRAC's vurderingsrapport om PSUR'en/PSUR'erne for desloratadin er CHMP 
nået frem til følgende videnskabelige konklusioner: </p>
<p>I lyset af tilgængelige data fra litteraturen inklusive i nogle tilfælde et tæt tidsmæssigt forhold, en 
positiv dechallenge og/eller rechallenge og i betragtning af en plausabel virkningsmekanisme 
overvejer PRAC, at en årsagssammenhæng mellem desloratadin og nedtrykt sindstilstand er i det 
mindste en rimelig mulighed. PRAC konkluderede at produktinformationen af produkter der 
indeholder desloratadin bør ændres i overenstemmelse hermed. </p>
<p>Som beskrevet i litteraturen og signal afsnittet af nogle indehavere af markedsføringstilladelserne 
(MAH’er), identificerede WHO et potentielt sikkerhedssignal i form af øjentørhed for desloratadin 
under rapporteringsperioden. Baseret på de antikolinergiske egenskaber vedrørende desloratadin, samt 
understøttet af rapporterne med kort tid til opståelse og både de- og rechallenge mekanismer, overvejer 
PRAC at "øjentørhed" bør overvejes medtaget på produktetiketter og i indlægssedler til patienter. </p>
<p>CHMP tilslutter sig PRAC's videnskabelige konklusioner. </p>
<p>Begrundelser for ændring af betingelserne for markedsføringstilladelsen/-tilladelserne </p>
<p>På baggrund af de videnskabelige konklusioner for desloratadin er CHMP af den opfattelse, at 
benefit/risk-forholdet for det lægemiddel/de lægemidler, der indeholder desloratadin, forbliver 
uændret under forudsætning af, at de foreslåede ændringer indføres i produktinformationen. </p>
<p>CHMP anbefaler, at betingelserne for markedsføringstilladelsen/-tilladelserne ændres. </p>         </div>"""      





                    
Instance: bundlepackageleaflet-en-d51291e7d675a24203f1a2e152221f98
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for desloratadine Package Leaflet for language en"
Description: "ePI document Bundle for desloratadine Package Leaflet for language en"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-d51291e7d675a24203f1a2e152221f98"
* entry[0].resource = composition-en-d51291e7d675a24203f1a2e152221f98

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpd51291e7d675a24203f1a2e152221f98"
* entry[=].resource = mpd51291e7d675a24203f1a2e152221f98
                            
                    
Instance: bundlepackageleaflet-da-d51291e7d675a24203f1a2e152221f98
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for desloratadine Package Leaflet for language da"
Description: "ePI document Bundle for desloratadine Package Leaflet for language da"
Usage: #example


* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #da

// Composition
* entry[0].fullUrl = "Composition/composition-da-d51291e7d675a24203f1a2e152221f98"
* entry[0].resource = composition-da-d51291e7d675a24203f1a2e152221f98

// MPD
* entry[+].fullUrl = "MedicinalProductDefinition/mpd51291e7d675a24203f1a2e152221f98"
* entry[=].resource = mpd51291e7d675a24203f1a2e152221f98
                            
                    



Instance: mpd51291e7d675a24203f1a2e152221f98
InstanceOf: MedicinalProductDefinitionUvEpi
Title: "Medicinal Product Desloratadine Teva 5 mg film-coated tablets"
Description: "Desloratadine Teva 5 mg film-coated tablets"
Usage: #inline

 
* identifier[+].system = "http://ema.europa.eu/identifier"
* identifier[=].value = "EU/1/11/732/001"
* type = http://hl7.org/fhir/medicinal-product-type#MedicinalProduct "Medicinal Product"

* domain = http://hl7.org/fhir/medicinal-product-domain#Human "Human use"

* status = http://hl7.org/fhir/publication-status#active "active"



* legalStatusOfSupply = $spor-rms#100000072084 "Medicinal product subject to medical prescription"

* name
  * productName = "Desloratadine Teva 5 mg film-coated tablets"
  * type = $spor-productNamePartType-cs#220000000001 "Full name" 
  
  * part[0]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000002 "Invented name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000003 "Scientific name part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000004 "Strength part"
  
  * part[+]
    * part = "nan"
    * type = $spor-productNamePartType-cs#220000000005 "Pharmaceutical dose form part"
  
  * usage
    * country = urn:iso:std:iso:3166#EU "EU"
    * jurisdiction = urn:iso:std:iso:3166#EU "EU"
    * language = urn:ietf:bcp:47#en  "en"



RuleSet: d51291e7d675a24203f1a2e152221f98ListRuleset

* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* identifier[+].system = "http://spor.ema.europa.eu/v2/medicine-name"
* identifier[=].value = "desloratadine"

* status = #current
* mode = #working

* title = "List of all ePIs associated with desloratadine"

* subject = Reference(mpd51291e7d675a24203f1a2e152221f98)
* subject.extension[0].url = "http://ema.europa.eu/fhir/extension/medicine-name"
* subject.extension[=].valueCoding = $100000000005#desloratadine "desloratadine"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/marketing-authorization-holder"
* subject.extension[=].valueCoding = $100000000005#mah-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/active-substance"
* subject.extension[=].valueCoding = $100000000005#acive-substance-code "None"
* subject.extension[+].url = "http://ema.europa.eu/fhir/extension/domain"
* subject.extension[=].valueCoding = $100000000004#100000000012 "H"

* date = "2015-02-07T13:28:17Z"


* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-en-d51291e7d675a24203f1a2e152221f98) // desloratadine en
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "en"



* entry
  * flag = urn:oid:1.2.36.1.2001.1001.101.104.16592#01
  * flag.text = "Unchanged"
  * date = "2015-02-07T13:28:17Z"
  * item = Reference(bundlepackageleaflet-da-d51291e7d675a24203f1a2e152221f98) // desloratadine da
  * item.extension[0].url = "http://ema.europa.eu/fhir/extension/documentType"
  * item.extension[=].valueCoding = $100000155531#100000155538 "B. PACKAGE LEAFLET"
  * item.extension[+].url = "http://ema.europa.eu/fhir/extension/language"
  * item.extension[=].valueCoding = $100000072057#100000072147 "da"




Instance: List-d51291e7d675a24203f1a2e152221f98
InstanceOf: List

* insert d51291e7d675a24203f1a2e152221f98ListRuleset
    